PAI
KLDO

Palo Alto Investors’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Palo Alto Investors’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-309,692
Closed -$511K – 35
2022
Q1 		$511K Sell
309,692
-31,338
-9% -$55.9K 0.04% 33
2021
Q4 		$815K Sell
341,030
-445,370
-57% -$1.81M 0.05% 33
2021
Q3 		$4.29M Hold
786,400
– – 0.26% 28
2021
Q2 		$5.85M Hold
786,400
– – 0.32% 26
2021
Q1 		$6.37M Hold
786,400
– – 0.36% 25
2020
Q4 		$7.16M Hold
786,400
– – 0.38% 23
2020
Q3 		$8.71M Hold
786,400
– – 0.48% 22
2020
Q2 		$5.84M Sell
786,400
-1,599
-0.2% -$10.7K 0.35% 24
2020
Q1 		$4.85M Hold
787,999
– – 0.41% 25
2019
Q4 		$3.96M Hold
787,999
– – 0.22% 24
2019
Q3 		$5.93M Sell
787,999
-78,667
-9% -$683K 0.4% 24
2019
Q2 		$10.1M Hold
866,666
– – 0.49% 26
2019
Q1 		$12.6M Buy
+866,666
New +$11.9M 0.52% 25

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Palo Alto Investors's KLDO Position: Q2 2022 in Review

Palo Alto Investors sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 309,692 shares — an estimated $511K sold.

Palo Alto Investors first reported a position in KLDO in Q1 2019 and held it in 13 quarters. The position peaked at $12.6M in Q1 2019. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Palo Alto Investors reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Palo Alto Investors sold 309,692 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $511K.
  • Palo Alto Investors first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Palo Alto Investors's Kaleido Biosciences, Inc. Common Stock position peaked at $12.6M in Q1 2019.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Palo Alto Investors's 13F filing for Q2 2022, filed 15 Aug 2022.